SETUP : Neoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response: A pilot study.

Female<br/>OnlyGender Female
Only

RecruitingStatus Recruiting

Systemic<br/>Therapy TrialTypeSystemic
Therapy Trial

ThreePhase Three

18-75Age 18-75

Breast<br/>CancersCancer LocationBreast
Cancers

Systemic therapy | BreastBreast

Trial Overview Read MoreRead more

This phase III trial is assessing the safety and effectiveness of neoadjuvant chemotherapy, with docetaxel and anthracycline, in patients with advanced breast cancer.
 

This trial is treating patients with breast cancer.

This is a systemic therapy trial.

You may be able to join this trial if:

  • Your cancer has not spread to other parts of the body.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

Neoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response: A pilot study.

Commercial Sponsor

Sanofi Aventis

Other Non-Commercial Sponsor

Southern Health

Summary

Patients will be given either docetaxcel or anthracycline based chemotherapy prior to surgery. The tumour will be measured both before and after after the chemotherapy. All the measurements including radiological and laboratory from the tumour tissue are then assessed. Trial runs for 24 weeks.

Recruiting Hospitals Read MoreRead more

Frankston Hospital
Frankston
Ms Theresa de Man
tdemann@phcn.vic.gov.au
03 9784 7290

Not Recruiting Hospitals Read MoreRead more

Closed

Monash Health, Medical Oncology
Clayton
Ms Karen Gillett
Karen.Gillett@monashhealth.org
(03) 8572 2018

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next